These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 36239832)

  • 1. RNA Editing Therapeutics: Advances, Challenges and Perspectives on Combating Heart Disease.
    Birgaoanu M; Sachse M; Gatsiou A
    Cardiovasc Drugs Ther; 2023 Apr; 37(2):401-411. PubMed ID: 36239832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine-to-Inosine RNA Editing in Health and Disease.
    Gatsiou A; Vlachogiannis N; Lunella FF; Sachse M; Stellos K
    Antioxid Redox Signal; 2018 Sep; 29(9):846-863. PubMed ID: 28762759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial RNA Editing with ADAR for Gene Therapy.
    Bhakta S; Tsukahara T
    Curr Gene Ther; 2020; 20(1):44-54. PubMed ID: 32416688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine Deaminases That Act on RNA (ADARs).
    Wang Y; Zheng Y; Beal PA
    Enzymes; 2017; 41():215-268. PubMed ID: 28601223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To protect and modify double-stranded RNA - the critical roles of ADARs in development, immunity and oncogenesis.
    Erdmann EA; Mahapatra A; Mukherjee P; Yang B; Hundley HA
    Crit Rev Biochem Mol Biol; 2021 Feb; 56(1):54-87. PubMed ID: 33356612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse models to elucidate the functional roles of adenosine-to-inosine editing.
    Rula EY; Emeson RB
    Methods Enzymol; 2007; 424():333-67. PubMed ID: 17662849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms and implications of ADAR-mediated RNA editing in cancer.
    Wang C; Zou J; Ma X; Wang E; Peng G
    Cancer Lett; 2017 Dec; 411():27-34. PubMed ID: 28974449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse functions for DNA and RNA editing in the immune system.
    Hamilton CE; Papavasiliou FN; Rosenberg BR
    RNA Biol; 2010; 7(2):220-8. PubMed ID: 20220309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript.
    Wheeler EC; Washburn MC; Major F; Rusch DB; Hundley HA
    RNA Biol; 2015; 12(2):162-74. PubMed ID: 25826568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-directed RNA editing by harnessing ADARs: advances and challenges.
    Li M; Yan C; Jiao Y; Xu Y; Bai C; Miao R; Jiang J; Liu J
    Funct Integr Genomics; 2022 Dec; 22(6):1089-1103. PubMed ID: 36282404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADARs, RNA editing and more in hematological malignancies.
    Teoh PJ; Koh MY; Chng WJ
    Leukemia; 2021 Feb; 35(2):346-359. PubMed ID: 33139858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Systematic Review of Common and Brain-Disease-Specific RNA Editing Alterations Providing Novel Insights into Neurological and Neurodegenerative Disease Manifestations.
    Karagianni K; Pettas S; Christoforidou G; Kanata E; Bekas N; Xanthopoulos K; Dafou D; Sklaviadis T
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA editing by base deamination: more enzymes, more targets, new mysteries.
    Gerber AP; Keller W
    Trends Biochem Sci; 2001 Jun; 26(6):376-84. PubMed ID: 11406411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral.
    Samuel CE
    Virology; 2011 Mar; 411(2):180-93. PubMed ID: 21211811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADARs and editing: The role of A-to-I RNA modification in cancer progression.
    Fritzell K; Xu LD; Lagergren J; Öhman M
    Semin Cell Dev Biol; 2018 Jul; 79():123-130. PubMed ID: 29146145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma.
    Qin YR; Qiao JJ; Chan TH; Zhu YH; Li FF; Liu H; Fei J; Li Y; Guan XY; Chen L
    Cancer Res; 2014 Feb; 74(3):840-51. PubMed ID: 24302582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide A-to-I RNA editing in fungi independent of ADAR enzymes.
    Liu H; Wang Q; He Y; Chen L; Hao C; Jiang C; Li Y; Dai Y; Kang Z; Xu JR
    Genome Res; 2016 Apr; 26(4):499-509. PubMed ID: 26934920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA epigenetics and cardiovascular diseases.
    Dorn LE; Tual-Chalot S; Stellos K; Accornero F
    J Mol Cell Cardiol; 2019 Apr; 129():272-280. PubMed ID: 30880252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA editing by adenosine deaminases generates RNA and protein diversity.
    Schaub M; Keller W
    Biochimie; 2002 Aug; 84(8):791-803. PubMed ID: 12457566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of RNA editing by intracellular acidification.
    Malik TN; Doherty EE; Gaded VM; Hill TM; Beal PA; Emeson RB
    Nucleic Acids Res; 2021 Apr; 49(7):4020-4036. PubMed ID: 33721028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.